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Herpes Simplex virus (HSV) protein ICP27 is a multifunctional gene expression regulator, which assumes various 
roles during the course of the viral infection. Previously we identified ICP27 switches RNA isoforms expression 
of particular genes such as PML (promyelocytic leukemia). Although ICP27 protein contains several RNA 
binding domains, it remains unclear what domain of ICP27 protein is critically important for RNA binding 
activity to both host and viral transcripts. Here we characterized the RNA binding activity of ICP27 protein in 
vitro. We found that R2 domain and three KH domains in the C terminal region of ICP27 protein bound to PML 
pre-mRNA and also suppressed retention of PML intron 7a, indicating that the C-terminal region contributes to 
such alternative splicing regulation of host gene. Notably C-terminal region of ICP27 protein efficiently binds to 
poly G, poly U and poly C, although the N-terminal region preferentially binds to poly G. In addition, the mutant 
proteins that lack either R2 or KH domains decreases RNA binding activity to poly U. We also employed Cross-
Linking and Immuno-Precipitation (CLIP)-PCR approach in HSV-2 infected cells and identified 39 RNA binding 
targets of ICP27 protein in the viral genome that is G-rich. Finally, we showed that loss of either the N or C 
terminal regions of ICP27 significantly impaired RNA binding to such viral RNAs. Overall our results suggest 
that combination of ICP27 protein domains determines specificity of RNA binding to host and HSV-2 RNAs. 
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Herpes Simplex Virus (HSV)-2 is a nuclear replicating 
DNA virus that causes many diseases [1-3]. HSV-2 hijacks 
host factors to facilitate its productive infection while it 
efficiently shuts down host gene expression. A tegument 
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protein VP16 recruits the host transcription machinery to 
express immediate early (IE) gene products, including 
Infected-cell protein (ICP)0, ICP4, ICP27, and ICP47 [3,4]. 
ICP27 is a multifunctional regulatory protein that is 
conserved throughout the Herpesviridae [5,6]. A primary 
function of ICP27 is regulation of delayed early (DE) and 
late (L) gene expression. For this purpose, ICP 27 utilizes 
several gene expression mechanisms, including transcript-
tion promotion through interacting with the C terminus of 
RNA polymerase II [7], modulating pre-mRNA splicing by 
interacting with splicing factors [8-10], regulation of 
transcription termination and 3’ end processing [11-14], 
and export of viral mRNAs from the nucleus to the 
cytoplasm [9,15,16].  
 
Previously we found that the expression of 
promyelocytic leukemia (PML) splicing isoforms was 
switched during HSV-2 infection by alternative splicing 
[10]. Our group has established a splicing reporter capable 
of visualization of alternative splicing events in vivo [17-22] 
and we have developed a virus-sensitive splicing reporter 
whose fluorescent protein expression is changed in HSV-2-
infected cells [10]. We identified ICP27 as an alternative 
splicing regulator for PML pre-mRNA and we found that it 
suppressed intron 7a removal presumably by modulating 3’ 
splice site recognition of the cellular trans-acting factor [10]. 
In addition, we found that RGG box of ICP27, which was 
assumed to be a major RNA binding domain of ICP27, was 
not required for PML-splicing regulation and KH domains 
at carboxy-terminus of ICP27 are critical for this step [10]. 
These results strongly suggested that carboxy-terminus of 
ICP27 including R2 domain and KH domains plays 
important roles in recognition of the ICP27 target RNAs 
including viral and host RNAs. 
 
Here we focused on RNA binding and splicing regulation 
activity of HSV-2 ICP27 protein. Our data show that ICP27 
is capable to bind PML pre-mRNA through its C-terminal 
domain and modulate its alternative splicing without RGG 
box. In vitro ribohomopolymer binding assays reveal that 
both R2 domain and KH domains in C-terminal region 
confer RNA binding activity. Furthermore, CLIP analysis 
demonstrates that ICP27 binds to many of HSV-2 mRNA. 
Electrophoretic Mobility Shift Assay (EMSA) demon-
strated that both N-and C-terminus regions of ICP27 can 
bind to viral RNAs, but less efficiently than the full-length 
protein. Our results strongly suggest that ICP27 binds to its 
target RNA through RGG box, R2 domain and KH domains 
cooperatively. 
 
Materials and Methods 
 
Plasmid Construction 
Construct expressing Flag-tagged ICP27 proteins 
prepared by inserting a PCR product of a total genome of 
HSV-2 recovered from infected Vero cells into the 
pcDNA3-Flag vector [10]. To construct Flag-tagged 
amino- and carboxyl- terminal deletion mutants, which are 
called as ICP27 (1-239) and ICP27 (240-512), respectively, 
the fragments containing corresponding regions of ICP27 
were prepared by PCR and cloned them into pENTR-
D/TOPO. Subsequently, ICP27 (1-239) and ICP27 (240-
512) in pENTR were converted to pDEST-pcDNA3-Flag 
destination vector by the LR reaction (invitrogen). The 
carboxyl-terminal deletion mutants, Flag-ICP27 (1-168), 
Flag-ICP27 (N:1-152) and Flag-ICP27(1-137) were 
prepared by PCR-based mutation (deletion) using 
QuikChange II XL kit (Stratagene). The amino-terminal 
deletion mutants, Flag-ICP27 (C:153-512) and Flag-
ICP27(168-512) were prepared in the same way. The 
amino- and carboxyl-terminal deletion mutants Flag-ICP27 
(153-450), Flag-ICP27 (153-367), Flag-ICP27 (153-281) 
and Flag-ICP27 (nls-C) were prepared in the same way. 
Flag-ICP27 (RGG) and Flag-ICP27 (M15) were previously 
described [10]. The primers used for cloning are shown in 
the supplementary Table S1.  
 
Viruses and Antibodies 
 
HSV-2 strain G was used at multiplicities of infection 
(MOI) based on their plaque-forming unit titers in Vero 
cells. Anti-Flag antibodies, anti-ICP27 (8.F.137B) and 
Normal mouse IgG were purchased from Sigma, Abcam 
and Santa Cruz, respectively. 
 
Cross-linking Immunoprecipitation (CLIP)-PCR of ICP27 
 
For a CLIP-PCR experiment of ICP27 in HSV-2 infected 
HeLa cells, we used the CLIP method reported by Ule et al 
[23,24]. HSV-2 infected HeLa cells (6hpi (hours post 
infection)) were UV crosslinked for a total of 400mJ/cm2 
using FUNA-CV-LINKER FS-800 (FUNAKOSHI, Japan) 
to covalently bond proteins and nucleic acids. To remove 
DNA, the soluble extract was treated with 30 U RQ DNase 
I (Promega) for 15 min at 37°C, and then incubated with 
RNaseA (4x10-5U/ul) to digest RNA for 10 min at 37°C. 
Subsequently, the extract was centrifuged at 60,000rpm 
using an Optima L-70k ultracentrifuge (BECKMAN 
COULTER, USA) in an NVT 65.2 rotor for 20 min at 4°C. 
The supernatant was mixed with either ICP27 antibody 
(abcam) or non-specific mouse IgG antibody (nacalai 
tesque, Japan) bound to Protein G Dynabeads (invitrogen). 
ICP27-RNA were immunoprecipitated from extract under 
stringent conditions (1 x PBS, 0.1% SDS, 0.5% deoxycho-
late, 0.5% NP-40). Purified ICP27-RNA complexes were 
modified using alkaline phosphatase (Takara Bio, Japan) 
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followed by ligation of an RNA linker sequences (5’-OH 
AGGGAGGACGAUGCGG3’-OH) (Dharmacon) and end-
labeling with [-32P] ATP by polynucleotide kinase (PNK) 
(Takara Bio, Japan). Subsequently, samples were size-
separated by 10% Nu-PAGE (Invitrogen) and transferred to 
nitrocellulose membranes. RNA species covalently bound 
to proteins on nitrocellulose membranes were identified by 
monitoring radioactivity. To purify RNA, small strips of 
nitrocellulose membranes corresponding to the highest 
signal were cut out and treated with proteinase K, and then 
precipitated overnight in ethanol with GlycoBlue (Ambion). 
Subsequently, a 5’ RNA linker (5’-P GUG UCA GUC 
ACU UCC AGC GG-3’ puromycin) was attached to the 
purified RNA. PCR was performed using primers specific 
for each RNA linker to amplify regions associated with 
ICP27. PCR products between 80-90 base pairs were then 
cut out of an acrylamide gel and cloned into pCR-Blunt II-
TOPO vector (invitrogen) and sequenced. 
 
In Vitro Ribohomopolymer Binding Assay 
 
In vitro translated proteins were synthesized using TnT 
(Transcription and Translation)-coupled reticulocyte 
lysates (Promega) and 35S-labeled methionine. Radiolabel-
ed proteins were incubated with ribohomopolymers 
conjugated to agarose beads (SIGMA) 10 min at 4 °C in a 
binding buffer (10 mm Tris-HCl, pH 7.4, 2.5 mm MgCl2, 
0.5% Triton X-100, 100 mm NaCl) and washed with the 
binding buffer. Finally, the bound proteins were analyzed 
by electrophoresis on SDS-PAGE and visualized by 
autoradiography [25-27]. 
 
EMSA (Electrophoretic Mobility Shift Assay) 
 
The 32P-labeled HSV-2 RNA probes containing CLIP tag 
were prepared by in vitro transcription with [α-32P] GTP 
and T7 RNA polymerase (Takara Bio, Japan) as described 
[10]. The PCR products of HSV-2 T7-UL27(2480-2579, 
100nt), T7-UL42(516-615, 100nt) and T7-UL26(1559-
1658, 100nt) were used as the DNA templates for T7 
transcription. The PCR primers are shown in 
supplementary Table S2. 
 
Ten femtomoles of each radiolabeled RNA probe were 
incubated with 500 fmoles of Flag-tagged ICP27 purified 
from T-Rex293 cells expressing Flag-ICP27 in RNA-
binding buffer I(20 mM HEPES-KOH at pH 7.9, 320 mM 
KCl, 5% glycerol, 1% Triton X-100, 1 mM DTT) with 
yeast tRNA for 30 min at 30°C. Each sample was separated 
on a nondenaturing polyacrylamide gel and visualized with 
a phosphorimage analyzer (FLA-3000G; Fuji Film). 
 
RNA immunoprecipitation 
Whole cell extracts were prepared from HEK293 cells 
transfected with plasmids expressing Flag alone, Flag-
ICP27(WT), Flag-ICP27(N) and Flag-ICP27(C). 32P-
labeled US12(1-261), UL27(2379-2678) and UL42(467-
716) of HSV-2 RNA were prepared by in vitro transcription 
with [-32P] GTP and T7 RNA polymerase (Takara Bio, 
Japan). PML exon 7-7b was prepared by in vitro 
transcription with [-32P] UTP and T7 RNA polymerase 
(Takara Bio, Japan). Gel purified RNA was incubated for 
30 min at 30°C with each nuclear extract in 20 µl of RNA 
binding buffer II [20 mM HEPES–KOH (pH 7.9), 100 mM 
KCl, 5% Glycerol, 1% Triton X-100, 2 mM DTT and 0.2 
mM PMSF] supplemented with 0.4 U of an RNase inhibitor 
(Promega), and immunoprecipitation was then performed 
with Flag-M2 antibody. Each RNA was purified by the 
protein removal and ethanol precipitation. The purified 
RNAs were analyzed by denaturing PAGE and imaging 
using a phosphorimage analyzer (FLA-3000G; FUJIFILM).  
 
Confocal immunofluorescence microscopy 
 
Twenty-four hours after the transfection, cells on 15-mm 
glass coverslips were fixed with 4% paraformaldehyde for 
10 min, permeabilized with 1% Triton X-100 for 20 min, 
blocked with the blocking solution (0.2% Gelatin, 1% BSA, 
0.05% Tween 20 in PBS) for 1h and reacted with a diluted 
primary antibody (rabbit anti- Flag polyclonal antibody) in 
the blocking solution for 12 h at 4°C. After incubation, cells 
were washed extensively with a washing buffer (0.05% 
Tween 20 in PBS (pH 8.0)), incubated for 2 h at room 
temperature with the appropriate secondary antibody 
(fluorescein isothiocyanate (FITC)-conjugated goat anti-
rabbit IgG) diluted in the blocking solution, and then 
washed three times with the washing solution. The cells 





ICP27 can bind to PML pre-mRNA without RGG box 
 
In order to examine whether ICP27 protein without RGG 
box can associate with PML pre-mRNA or not, we 
performed RNA immunoprecipitation assay with ICP27 
WT, ICP27 N, ICP27 C and ICP27 RGG proteins. The 
ICP27 N protein contains N-terminal 152 amino acids that 
include RGG box, whereas ICP27 C protein contains R2 
and three KH domains (C-terminal 360 amino acids). The 
pre-mRNAs containing from exon 7 to exon 7b region were 
synthesized by in vitro transcription in the presence of [- 
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Figure 1. Binding activity of ICP27 wild type and the truncation mutants to the PML pre-mRNA. (A) 
Schematic representation of the ICP27 wild type and mutant proteins. (B) Immunoprecipitations were carried out 
after incubation of 32P-labeled PML pre-mRNA under in vitro splicing reaction condition. For inclusion of Flag-
ICP27 in the reaction, HeLa nuclear extract was added with total cell extract from HEK293T cells that had been 
transfected with control plasmid (Flag-pcDNA3, vector, lanes 1 and 6) or Flag-ICP27 wild type (lanes 2 and 7) or 
various deletion mutants (lanes 3-5 and 8-10). Flag monoclonal antibody M2 was used for immunoprecipitations. 
(C) Western blotting of the extracts from the cells transfected with control plasmid (vector) or Flag-ICP27 wild 
type and mutant proteins (Flag-ICP27 WT, N, C or DRGG). The Flag-ICP27 proteins were detected using 
monoclonal antibody to Flag. 
 
 
32P] UTP, and then RNAs were mixed with the whole cell 
extracts from HEK293 cells expressing Flag tagged 
proteins complemented by HeLa cell nuclear extracts. The 
expression level of those proteins was determined by 
western blotting with anti-Flag tag antibody and we found 
that all proteins were almost equally expressed (Figure 1C). 
Following incubation, RNAs were immunoprecipitated 
with anti-Flag antibody. The results in Figure 1B showed 
that Flag-ICP27 WT was able to precipitate PML pre-
mRNA, while the negative control (vector transfected) was 
not (lanes 1 and 6). Interestingly, Flag-ICP27 C and ICP27 
RGG which do not have an RGG box also precipitated PML 
pre-mRNA (lanes 9 and 10). Surprisingly, Flag-ICP27 N 
that contains RGG box was not able to precipitate with 
PML pre-mRNA (Figure 1B, lane 8). These results indicate 
that ICP27 is able to associate with PML pre-mRNA 
without RGG box. 
 
C-terminal region of ICP27 can modulate the PML pre-
mRNA alternative splicing 
Next we have examined whether the C-terminal region 
of ICP27 that does not have RGG box was able to alter 
PML alternative splicing or not. The E6-7b reporter, which 
was previously described [10], was transfected into 
HEK293 cells together with wild type or several mutants of 
ICP27 (Figure 2A). Both wild type and mutants of ICP27 
were confirmed their nuclear localization by expressing 
them in HeLa cells, followed by immunofluorescence with 
anti-Flag-tag antibody (Figure 2C). Alternative splicing 
pattern was determined by RT-PCR analysis of RNAs 
recovered from HEK293 cells (Figure 2B, upper panel). As 
we previously reported, overexpression of ICP27 wild type 
and RGG switch PML alternative splicing from intron 7a 
removal to retention (Figure 2B, lanes 3 and 6), while M15 
that has a point mutation in KH3 domain of ICP27 failed to 
switch the alternative splicing of PML pre-mRNA (Figure 
2B, lane 7) [10]. Interestingly, both nls-C and RGG mutants 
retained the promotion activity for intron 7a retention same 
as ICP27 WT (Figure 2B, lanes 5 and 6). The effect of this 
PML splicing by ICP27 N was still inconclusive, since the  
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Figure 2. Effects of ICP27 mutants on PML pre-mRNA splicing in cells. (A) Schematic representation of the ICP27 wild type and mutant proteins. 
(B) Upper panel: RT-PCR analysis of HEK293 cells transfected with Flag-tagged ICP27 wild type or mutant plasmids in combination with PML 
splicing reporter plasmid. GAPDH was used as a control. Lower panel: Western blot analysis of HEK293 cell whole cell extracts transfected with Flag-
tagged ICP27 wild-type or mutant plasmids. Flag-tagged proteins were detected by anti-Flag monoclonal antibody. GAPDH protein was employed as 
a loading control. (C) Immunofluorescence of HeLa cells transfected with either Flag-tagged ICP27 wild-type or the mutant plasmids with anti-flag 
antibody. Hoechst staining indicates HeLa cell nuclei. 
 
 
expression level of this protein was much lower than others 
(Figure 2B, lower panel, lane 4). These results indicate that 
C-terminal region of ICP27 containing R2 and KH domains 
has an important role in the regulation of PML alternative 
splicing. 
 
Binding properties of ICP27 wild type and truncation 
mutants to RNA homopolymers 
 
The results described above strongly suggested that R2 
domain and KH domains of ICP27 have an RNA binding 
activity. In order to test whether C-terminal region of ICP27 
harbors a general RNA binding activity or not, we took 
advantage of in vitro ribohomopolymers binding assays. 
This assay was commonly used for testing RNA binding 
activity of several RNA binding proteins [28,29]. For the 
binding assays, full-length and truncated ICP27 proteins 
(Figure 3A) were synthesized by in vitro transcription and 
translation in a rabbit reticulocyte lysate in the presence of 
35S-methionine. The radiolabeled proteins were incubated 
with RNA homopolymers beads, and bound proteins were 
analyzed by SDS-PAGE. The full length ICP27 protein 
bound to poly G and poly U and weakly to poly C (Figure 
3B, lanes 2-5). ICP27 N bound strongly to poly G, but 
weekly to poly U and C (Figure 3B, lanes 7-10). ICP27 C 
was then tested its binding properties with this assay, and 
we found that it bound poly G and poly U and slightly 
weakly to poly C, which is quite similar to those of the full 
length ICP27 (Figure 3B, lanes 12-15). These results 
indicate that downstream region of RGG box in ICP27 have 
an RNA binding activity that prefers poly G and poly U. To 
further identify the critical region for RNA binding activity 
of ICP27 C, we also analyzed the ability of N-terminal 
truncated mutants of ICP27 C to bind ribohomopolymers 
(Figure 3C). For these assays we used poly G and poly U 
ribohomopolymers, since ICP27 WT binds strongly to them. 
As well as wild type, ICP27 C bound strongly to poly G and 
poly U ribohomopolymers (Figure 3D, lanes 5 and 6). 
Deletion of R2 domain caused the loss of binding activity 
to poly U (Figure 3D, lane 9). The deletion of KH domains 
from ICP27 C also abolished binding activity to poly U 
(Figure 3D, lane12). Taken together, these results indicate 
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Figure 3. RNA-Binding properties of ICP27 wild type and truncated mutant proteins. (A) Schematic diagram of ICP27 and the N- and C-terminal 
truncated mutants used for in vitro binding experiments with ribonucleotide homopolymers. (B) Binding of the ICP27 protein to ribonucleotide 
homopolymers. Flag-tagged ICP27 proteins were synthetized by in vitro transcription and translation in rabbit reticulocyte lysate programmed with 
cDNA encoding ICP27 wild type and truncation mutants in the presence of [35S] methionine. Labeled proteins bound to the indicated ribohomopolymers 
(lanes A, C, G and U) were analyzed by SDS-PAGE followed by fluorography. An amount equivalent to 10% of the material used for each binding 
reaction is shown in the lanes marked Input. The positions of molecular mass markers are indicated on the left side of the panel. (C) Schematic 
representation of ICP27 and the various C-terminal mutants used for in vitro binding experiments with ribonucleotide homopolymers. (D) Binding of 
the ICP27 WT and mutant proteins to poly G and poly U homopolymers. Bound proteins were analyzed as in (A). 
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Figure 4. Identification of ICP27-bound RNA by CLIP. (A) (Left panel) Immunoblot analysis of ICP27 IP using anti-ICP27 
antibody. (Right panel) HeLa cells infected by HSV-2 were irradiated with or without UV. Protein–RNA complexes were 
immunoprecipitated with anti-ICP27 antibody, and the 5’ ends of immunoprecipitated RNAs were radiolabeled with 32P. Proteins 
cross-linked with radiolabeled RNAs were separated by SDS-PAGE and visualized by autoradiography. RNA–protein complexes 
(indicated by a bracket) are seen with ICP27 immunoprecipitants dependent on UV irradiation but not control and IgG 
immunoprecipitation. (B) Annotated list of ICP27 CLIP tags derived from viral RNAs. 
RNA & DISEASE 2020; 7: e1165. doi: 10.14800/rd.1165; ©  2020 by Hidenobu Kawamura, et al. 
http://www.smartscitech.com/index.php/rd 
 




Figure 5. Both N- and C-terminal regions of ICP27 bind to viral RNAs. (A) EMSA with Flag-ICP27 proteins and in vitro 
synthesized viral RNAs. Ten fmol of radiolabeled RNA probes were incubated with 500 fmol of either BSA or recombinant Flag-
ICP27 WT protein. Each mixture was separated on a nondenaturing polyacrylamide gel and visualized with a phosphorimage 
analyzer (FLA-3000G; Fuji Film). (B) Schematic representation of Flag-tagged recombinant ICP27 proteins used for EMSA. (C) 
EMSA with Flag-ICP27 proteins and in vitro synthesized viral RNAs. Ten fmol of radiolabeled RNA probes were incubated with 
500 fmol or 1000 fmol of either BSA or recombinant Flag-ICP27 WT, N or C proteins. Each mixture was separated and analyzes as 
in (A). Arrowheads indicate the probe-Flag-ICP27 (N) protein complexes.  
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that both R2 domain and KH domains are necessary for 
binding activity of ICP27 to poly U ribohomopolymer. It is 
highly likely that both R2 and KH domains are required for 
specific and efficient binding of ICP27 to RNAs. 
 
Identification of ICP27-bound RNAs by CLIP under HSV-
2 infection 
 
With the results described above, ICP27 was shown to 
specifically bind to PML pre-mRNA and poly G and U. 
Since ICP27 likely binds to viral RNAs to regulate their 
processing, we tried to identify ICP27-bound RNAs 
comprehensively including HSV-2 RNAs during HSV-2 
infection. For this purpose, we employed a Cross-Linking 
and Immuno-Precipitation (CLIP)-PCR experiment using 
HSV-2 infected cells [23,24]. Extracts were prepared from 
UV-treated HSV-2 infected HeLa cells (6hpi) and treated 
with RNase A (4x10-5U/ul) to partially degrade cross-
linked RNA molecules. ICP27 protein was immunopreci-
pitated from extract under stringent conditions. The 
complexes were resolved on 10% Novex NuPage gels and 
transferred to nitrocellulose membrane. The molecular 
weight of ICP27 in NuPAGE is about 57kDa (Figure 4A). 
The RNA-ICP27 complexes immunoprecipitated by the 
anti-ICP27 antibody were separated by NuPAGE and 
shown in Figure 4A. The ICP27 proteins bound to RNA 
showed larger molecular weights than free ICP27 protein.  
 
We next recovered RNAs from the radioactively labeled 
RNA from smeared bands (Figure 4A) of sample 
immunoprecipitated by anti-ICP27 antibody (Figure 4A, 
lane 3) or nonspecific mouse IgG (Figure 4A, lane 2), and 
those RNAs were separated by denaturing PAGE (Figure 
4A). The length of RNA purified from complexes was 
about 35-40nt (data not shown). We then ligated a 5’RNA 
linker to the recovered RNAs and amplified by RT-PCR. 
Amplicons were cloned into TOPO vector and sequenced. 
We could obtain 265 CLIP tag sequences as putative ICP27 
RNA targets and analyzed by BLAST (http://blast.ddbj. 
nig.ac.jp/top-j.html) search to align sequences to the human 
and HSV-2 genome. Thirty-nine CLIP tags were mapped to 
39 positions in 28 HSV-2 genes (Figure 4B). As expected, 
many of CLIP tag contain G and U rich sequences. 
 
Since we could obtain many of HSV2 RNA as CLIP tags, 
EMSAs were performed with the 100nt RNAs that contain 
CLIP tags as probes to confirm ICP27 directly binds to 
those RNAs. As shown in Figure 5A, all CLIP tag RNAs 
tested by EMSA bound to ICP27 with different binding 
efficiencies. These results indicate that ICP27 directly 
binds to CLIP tag RNAs derived from HSV2 genome. Next 
we tested whether C-terminal region of ICP27 contributes 
to binding of ICP27 to viral RNAs by performing EMSAs 
with ICP27 WT, ICP27 N, ICP27 C (Figure 5B) and the 
100nt RNAs of UL27 and UL42 that bound to ICP27 WT 
efficiently as in Figure 5A. The results in Figure 5C showed 
that Flag-ICP27 WT was able to bind viral RNAs in a dose 
dependent manner. Flag-ICP27 N and C also bound viral 
RNAs, but less efficiently than a full-length protein (Figure 
5C). The shift of both RNAs with Flag-ICP27 N was much 
smaller than that of WT or C, which is likely due to the 
small size of Flag-ICP27 N protein (Figure 5C, lanes 7 and 
16). These results strongly suggest that not only RGG box 
but also R2 domain and KH domains bind HSV-2 RNAs 





In this study, we found that C-terminus region including 
from R2 to KH1, KH2 and KH3 domains of HSV-2 ICP27 
harbors RNA binding activity. Previously, it was assumed 
that RGG box of ICP27 confers RNA binding activity 
[30,31]. To our surprise, at least in in vitro binding assay to 
PML pre-mRNA, C-terminal region of ICP27, not N-
terminal portion, binds to PML-pre-mRNA (Figure 1). In 
addition, RGG box is not required for splicing modulation 
for PML pre-mRNA (Figure 2). These results strongly 
suggest that R2 and KH domains of ICP27 are involved in 
pre-mRNA splicing regulation via RNA binding activity.  
 
The ICP27 was shown to recruit predominantly 
cytoplasmic splicing factor kinase SRPK1 into the nucleus 
through binding with RGG box. This results in the aberrant 
phosphorylation of a family of essential splicing factors 
termed SR proteins, which are specifically phosphorylated 
by SRPK1 [8]. The inappropriate phosphorylation of SR 
proteins prevents their participation in spliceosome 
assembly, which causes splicing complex formation to stall, 
and host cell pre-mRNA splicing is impaired. Since RGG 
box of ICP27 is not necessary for PML splicing regulation 
(Figure 2), inhibition of splicing by ICP 27 is likely 
mediated by a different mechanism. We have already 
established in vitro splicing system using Flag-ICP27 
recombinant protein and PML pre-mRNA [10]. Further 
experiments with this system will shed light on the 
molecular mechanism how ICP27 inhibits splicing. 
 
The C-terminal region of ICP27 consists of two kinds of 
motifs, R2 and K-homology (KH) domains. This region 
contains three predicted KH domains. The C-terminal 
region of ICP27 contains three predicted K-homology (KH) 
domains. The KH domain was first identified in the human 
hnRNP K protein [32]. KH domains are often found in 
multiple copies in RNA binding proteins. For example, 
fragile X mental retardation protein (FMRP) has two KH 
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domains [32], and hnRNP K [28] and Nova-1, 2 [33,34], 
Mer1p [35] proteins have three KH domains. Although it 
had been implicated that KH domains of ICP27 bind to 
RNA, RNA or ssDNA binding activity was not 
demonstrated. Rather, it was assumed that KH3 domain of 
HSV-1 interacts with splicing regulators and mRNA export 
factors, such as SR proteins, SF3B2 (SAP145), Aly/REF 
and NXF1 [8,15,16,36]. With ribohomopolymer binding 
assays, C-terminal region of ICP27 binds to poly G, U and 
C (Figure 4). When either of the motif is deleted, the RNA 
activity of this domain is greatly reduced, and it shows 
binding activity only for poly G ribohomopolymers. This 
indicates that the combination of R2 and KH domains is 
required for poly U binding. Since the C-terminal domain 
of ICP27 could bind various ribohomopolymers than RGG 
box did (Figure 3B), it may recognize more specific 
sequences than RGG box. Our CLIP-PCR experiment 
identified many of viral RNAs associated with ICP27 
(Figure 4C). EMSA demonstrated its specific binding to 
those RNAs (Figure 5A). Although both N- and C-terminal 
regions of ICP27 were able to bind viral RNAs, the 
efficiency was lower than that of the full-length protein 
(Figure 5C). It is likely that N- and C-terminal regions 
cooperatively recognize and bind to target RNAs of ICP27. 
It is of interest to investigate binding RNA sequences with 
an ICP27 full-length, N- and C-terminal proteins by in vitro 
selection and compare the sequences obtained with each 
protein.  
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Table S2. PCR primers used for EMSA probe preparation. 
 
